financetom
Business
financetom
/
Business
/
Travelers Companies Insider Sold Shares Worth $776,727, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Travelers Companies Insider Sold Shares Worth $776,727, According to a Recent SEC Filing
May 2, 2024 2:13 PM

04:51 PM EDT, 05/02/2024 (MT Newswires) -- Jeffrey P. Klenk, Executive Vice President & President, Bond & Specialty Insurance, on May 01, 2024, sold 3,635 shares in Travelers Companies ( TRV ) for $776,727. Following the Form 4 filing with the SEC, Klenk has control over a total of 6,075 shares of the company, with 6,075 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/86312/000112760224013988/xslF345X03/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hologic Insider Sold Shares Worth $1,241,296, According to a Recent SEC Filing
Hologic Insider Sold Shares Worth $1,241,296, According to a Recent SEC Filing
Mar 15, 2024
04:16 PM EDT, 03/15/2024 (MT Newswires) -- Scott T Garrett, Director, on March 14, 2024, sold 16,441 shares in Hologic ( HOLX ) for $1,241,296. Following the Form 4 filing with the SEC, Garrett has control over a total of 48,611 shares of the company, with 48,611 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/859737/000112760224010261/xslF345X03/form4.xml Price: 75.92, Change: +0.01, Percent Change: +0.01...
Avidity Biosciences Insider Sold Shares Worth $980,760, According to a Recent SEC Filing
Avidity Biosciences Insider Sold Shares Worth $980,760, According to a Recent SEC Filing
Mar 15, 2024
04:16 PM EDT, 03/15/2024 (MT Newswires) -- Michael F MacLean, Chief Financial Officer, on March 13, 2024, sold 40,000 shares in Avidity Biosciences ( RNA ) for $980,760. Following the Form 4 filing with the SEC, MacLean has control over a total of 44,093 shares of the company, with 44,093 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1599901/000159990124000044/xslF345X03/wk-form4_1710533514.xml ...
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing
Mar 15, 2024
04:15 PM EDT, 03/15/2024 (MT Newswires) -- Soleil Boughton, Chief Legal Officer, on March 13, 2024, sold 63,621 shares in Hims & Hers Health ( HIMS ) for $965,016. Following the Form 4 filing with the SEC, Boughton has control over a total of 154,345 shares of the company, with 154,345 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000059/xslF345X03/wk-form4_1710533549.xml ...
Moody's upgrades New York Bancorp's long-term rating to B2
Moody's upgrades New York Bancorp's long-term rating to B2
Mar 15, 2024
March 15 (Reuters) - Ratings agency Moody's said on Friday it has upgraded New York Community Bancorp's ( NYCB ) long-term issuer rating to B2. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved